Exploratory research for markers of efficacy of treatment for inflammatory bowel disease

Exploratory research for markers of efficacy of treatment for inflammatory bowel disease - Exploratory research for markers of efficacy of treatment for IBD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023304

Enrollment

230

Registered

2016-08-01

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with IBD before remission induction therapy(regardless of a prior treatment)

Exclusion criteria

Exclusion criteria: 1. patients with a history of bowel resection(exclude appendectomy) 2. patients during pregnancy and lactation 3. patients who wish to become pregnant 4. patients who have an abdominal infection including an abdominal abscess 5. patients during chemotherapy and immunosuppressant therapy 6. patients with a history of a malicnant disease 7. patients who are ruled unfit to this study by doctors

Design outcomes

Primary

Measure	Time frame
To show a correlation between therapeutic response of the remission-induction therapy and biomarkers.	—

Countries

Japan

Contacts

Public ContactKosuke Yoshida

Keio university hospital Gastroenterology

borg768@keio.jp03-5843-7090

Outcome results